Evidence map›Paper›PMID 41927283›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry-An FNIH Joint Academic, Clinical, and Industrial Collaboration.

Dale L Bailey, John C Dickson, Suzanne E Lapi, Carlos Uribe, Clarita Saldarriaga Vargas, Price Jackson, Caroline Stokke, Julia Brosch-Lenz, Althea Lang, Stephen A Graves and 1 more

Abstract readEditorial
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dale L BaileyDepartment of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia; dale.bailey@sydney.edu.au.
John C DicksonInstitute of Nuclear Medicine, University College London Hospitals Foundation Trust, London, United Kingdom.
Suzanne E LapiDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
Carlos UribeMolecular Imaging and Therapy, BC Cancer, Vancouver, British Columbia, Canada.
Clarita Saldarriaga VargasDosimetry Research for Targeted Radionuclide Therapy, Belgian Nuclear Research Centre, Mol, Belgium.
Price JacksonDepartment of Physical Sciences, Peter MacCallum Cancer Centre, Melbourne, Australia.
Caroline StokkeDepartment of Physics and Computational Radiology, Oslo University Hospital, Oslo, Norway.
Julia Brosch-LenzInstitute of Nuclear Medicine, Bethesda, Maryland.
Althea LangFoundation for the National Institutes of Health, Bethesda, Maryland; and.
Stephen A GravesDepartment of Radiology, University of Iowa, Iowa City, Iowa.
John J SunderlandDepartment of Radiology, University of Iowa, Iowa City, Iowa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41927283
PMCPMC13435561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.